企業プロフィール
Charles River 株価・ニュース・カタリスト
- ティッカー:
- CRL
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
286.64 USD (+2.35%)
終値
最終更新: 2026年8月17日
8.42B USD
時価総額
株価変動の要因
As of Aug 17, 2026, CRL closed up 2.35% at $286.64. No new same-company headline was identified in the current news window.
企業概要
Preclinical Research Services
Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development.
Research Models and Services
The company supplies research models and related services used in basic research, target validation and preclinical studies. It also provides safety-assessment and discovery services.
Manufacturing Solutions
Charles River supports biologic testing, microbial solutions and other quality-control activities used in pharmaceutical manufacturing. Following divestitures, the company is refocusing on its core research and preclinical portfolio.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。